Glucose Metabolism Disorders  >>  Synjardy (empagliflozin/metformin)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synjardy (empagliflozin/metformin) / Boehringer Ingelheim, Eli Lilly
NCT01211197: Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

Completed
1
16
Europe
C: BI 10773 / metformin tablet, B: BI 10773 tablet and metformin tablet, A: BI 10773 / metformin tablet
Boehringer Ingelheim
Diabetes Mellitus, Type 2
12/10
 

Download Options